Summit
Device Ortho-Hip
PDI 10603295060147
General payments
$26,976,670
Research payments
$821,500
Through program year 2025, $26,976,670 in general payments and $821,500 in research payments were reported against Summit (Ortho-Hip).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $5,476,079 | 65 |
| 2025 | Research | $257,575 | 17 |
| 2024 | General | $3,825,850 | 64 |
| 2024 | Research | $226,931 | 33 |
| 2023 | General | $4,907,152 | 79 |
| 2023 | Research | $199,125 | 20 |
| 2022 | General | $4,488,111 | 86 |
| 2022 | Research | $114,075 | 20 |
| 2021 | General | $8,279,477 | 157 |
| 2021 | Research | $23,794 | 11 |
Breakdown
The top 5 of 10 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
451 general · 101 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.